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TRENAL DENERVATION
CRT-711
Accessory Renal Arteries And Blood Pressure-lowering Effects Of Renal
Denervation: Analysis From The Reduce-HTN Study
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BACKGROUND The bipolar radiofrequency Vessix Renal Denervation System (Boston
Scientiﬁc, Marlborough, MA) can be used in small arteries, allowing resistant hyper-
tension patients with accessory renal arteries to be included in the REDUCE-HTN
study.
METHODS Accessory renal arteries were identiﬁed and treated in 24 patients during
study procedures. Another 19 patients had accessory arteries that were later identi-
ﬁed in core lab angiographic analysis (ie, untreated accessory arteries). In post hoc
analyses, BP changes were compared between patients with treated vs untreated
accessory arteries, and between patients with accessory arteries (according to the
core lab) vs without.
RESULTS At both 6 and 12 months, all 4 patient subgroups had signiﬁcant ofﬁce
systolic BP reductions (p0.0004). For patients with treated accessory arteries, mean
ofﬁce BP decreased from 178.016.1/99.111.2 mmHg at baseline to 157.026.3/
86.814.5 mmHg at 6 months, and for patients with core lab-identiﬁed but untreatedaccessory arteries, ofﬁce BP decreased from 188.817.5/103.813.2 mmHg to
155.228.0/88.011.8 mmHg. None of the 6- or 12-month pairwise comparisons of
systolic BP for patients with treated vs untreated accessory arteries, or for those with
accessory arteries vs without, reached statistical signiﬁcance (Table). In linear
regression models, neither presence nor treatment of accessory arteries was signiﬁ-
cantly associated with the change in ofﬁce systolic BP.
CONCLUSION Presence of accessory renal arteries does not prevent signiﬁcant BP
reductions following renal denervation treatment. Due to the small sample sizes,
these unpowered post hoc analyses do not conclusively address the degree to which
accessory renal artery denervation may affect BP-lowering efﬁcacy.Table. Ofﬁce and 24-hours Ambulatory Systolic Blood Pressures and Accessory RenalCRT-712
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BACKGROUND Clinical and preclinical studies suggest that the efﬁcacy of RF renal
denervation (RDN) increases with increasing number of treatments. We evaluated
efﬁcacy and safety of the 9-electrode, 5-Fr, over-the-wire, RF ‘basket’ catheter, along
with simultaneous bipolar/unipolar therapy algorithm ReDy system (Renal Dynamics,
NJ) in pigs. Two catheter conﬁgurations were contrasted, with and without a ‘basket’-
covering membrane designed to minimize blood ﬂow at the electrode/tissue interface
thus minimizing shunting of RF power through blood.
METHODS Seven juvenile Yorkshire swine underwent bilateral temperature-
controlled RDN using the ReDy system. A single catheter size was used on all arteries
as the ReDy device accommodates artery diameters up to 6.5mm. Pigs were sacriﬁced
7-30d post treatment. Arteries were harvested for histopathology and kidneys pro-
cessed for norepinephrine (NEPI) quantiﬁcation.
RESULTS There was no angiographic evidence of acute dissection, perforation, or
occlusion at the time of the procedure. Macroscopic inspections of catheters post-
removal showed no adherent thrombus. Angiographic assessments showed the lu-
mens of all arteries were patent. Histologically, zones of treatment within arterial
walls and surrounding adventitia were well-demarcated at 7d with resolution of tis-
sue response over time. There was no evidence of any adverse effects on arteries or
surrounding tissue, and all treated arterial sections exhibited advanced re-
endothelialization.
The use of blood isolation membranes allowed for lower treatment powers (1.20.8
vs 1.40.2 W) and temperatures (63.66.3 vs 682.3 C) while increasing ablation
depth (5.02.6 vs 2.80.8 mm, p¼0.025) and percentage of affected nerves (37 vs
21%, P¼NS) at 7d, as estimated by histology and conﬁrmed by a signiﬁcant 60%
reduction in NEPI (256250 vs 634250 ng/g, p¼0.007). Tissue response was noted
in all quadrants and w65% of the artery length. Though radial adventitial response
was more compact at 30d, due to tissue repair, the percentage of affected nerves
(35%) and NEPI levels (365132 ng/g) were statistically equivalent to 7d values
(p>0.46).
CONCLUSION The Renal Dynamics ReDy system is safe and efﬁcacious in a porcine
RDN model. Utilization of non-occluding blood isolation membranes allowed for deep
delivery of RF power into the tissue at relatively low treatment powers, at multiple
axial and circumferential locations.
